{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:42:14Z","timestamp":1792820534636,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s10038-021-00899-w","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T13:19:54Z","timestamp":1611321594000},"page":"647-657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An integrated clinical and molecular study of a cohort of Turkish patients with Marfan syndrome harboring known and novel FBN1 variants"],"prefix":"10.1038","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2432-9279","authenticated-orcid":false,"given":"Alper","family":"Gezdirici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9964-6383","authenticated-orcid":false,"given":"Kerem","family":"Teral\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Y\u0131lmaz","family":"G\u00fclec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Bornaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Recep","family":"Er\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"899_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/humu.22977","volume":"37","author":"A Verstraeten","year":"2016","unstructured":"Verstraeten A, Alaerts M, Van Laer L, Loeys B. Marfan syndrome and related disorders: 25 years of gene discovery. Hum Mutat. 2016;37:524\u201331.","journal-title":"Hum Mutat"},{"key":"899_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jmg.2009.072785","volume":"47","author":"BL Loeys","year":"2010","unstructured":"Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476\u201385.","journal-title":"J Med Genet"},{"key":"899_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0754-6","volume":"13","author":"VM Becerra-Munoz","year":"2018","unstructured":"Becerra-Munoz VM, Gomez-Doblas JJ, Porras-Martin C, Such-Martinez M, Crespo-Leiro MG, Barriales-Villa R, et al. The importance of genotype-phenotype correlation in the clinical management of Marfan syndrome. Orphanet J Rare Dis. 2018;13:16.","journal-title":"Orphanet J Rare Dis"},{"key":"899_CR4","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/hmg\/4.suppl_1.1799","volume":"4","author":"HC Dietz","year":"1995","unstructured":"Dietz HC, Pyeritz RE. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet. 1995;4:1799\u2013809. Spec No","journal-title":"Hum Mol Genet"},{"key":"899_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mrrev.2015.04.002","volume":"765","author":"KA Zeyer","year":"2015","unstructured":"Zeyer KA, Reinhardt DP. Engineered mutations in fibrillin-1 leading to Marfan syndrome act at the protein, cellular and organismal levels. Mutat Res Rev Mutat Res. 2015;765:7\u201318.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"899_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.str.2011.12.008","volume":"20","author":"SA Jensen","year":"2012","unstructured":"Jensen SA, Robertson IB, Handford PA. Dissecting the fibrillin microfibril: structural insights into organization and function. Structure 2012;20:215\u201325.","journal-title":"Structure"},{"key":"899_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","volume":"136","author":"PD Stenson","year":"2017","unstructured":"Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet. 2017;136:665\u201377.","journal-title":"Hum Genet"},{"key":"899_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ymgme.2012.07.023","volume":"107","author":"MR Davis","year":"2012","unstructured":"Davis MR, Summers KM. Structure and function of the mammalian fibrillin gene family: implications for human connective tissue diseases. Mol Genet Metab. 2012;107:635\u201347.","journal-title":"Mol Genet Metab"},{"key":"899_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"899_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/humu.10249","volume":"22","author":"G Collod-Beroud","year":"2003","unstructured":"Collod-Beroud G, Le Bourdelles S, Ades L, Ala-Kokko L, Booms P, Boxer M, et al. Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Hum Mutat. 2003;22:199\u2013208.","journal-title":"Hum Mutat"},{"key":"899_CR11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/humu.23555","volume":"39","author":"A Henrie","year":"2018","unstructured":"Henrie A, Hemphill SE, Ruiz-Schultz N, Cushman B, DiStefano MT, Azzariti D, et al. ClinVar miner: demonstrating utility of a Web-based tool for viewing and filtering ClinVar data. Hum Mutat. 2018;39:1051\u201360.","journal-title":"Hum Mutat"},{"key":"899_CR12","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.jmb.2019.04.009","volume":"431","author":"S Ittisoponpisan","year":"2019","unstructured":"Ittisoponpisan S, Islam SA, Khanna T, Alhuzimi E, David A, Sternberg MJE. Can predicted protein 3D structures provide reliable insights into whether missense variants are disease associated? J Mol Biol. 2019;431:2197\u2013212.","journal-title":"J Mol Biol"},{"key":"899_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/humu.9207","volume":"23","author":"A Biggin","year":"2004","unstructured":"Biggin A, Holman K, Brett M, Bennetts B, Ades L. Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy. Hum Mutat. 2004;23:99.","journal-title":"Hum Mutat"},{"key":"899_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.str.2004.02.023","volume":"12","author":"SS Lee","year":"2004","unstructured":"Lee SS, Knott V, Jovanovic J, Harlos K, Grimes JM, Choulier L, et al. Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization. Structure 2004;12:717\u201329.","journal-title":"Structure"},{"key":"899_CR15","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/pro.5560030923","volume":"3","author":"A Sali","year":"1994","unstructured":"Sali A, Overington JP. Derivation of rules for comparative protein modeling from a database of protein structure alignments. Protein Sci. 1994;3:1582\u201396.","journal-title":"Protein Sci."},{"key":"899_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.ejhg.5200582","volume":"9","author":"F Tiecke","year":"2001","unstructured":"Tiecke F, Katzke S, Booms P, Robinson PN, Neumann L, Godfrey M, et al. Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40. Eur J Hum Genet. 2001;9:13\u201321.","journal-title":"Eur J Hum Genet"},{"key":"899_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1399-0004.2008.01007.x","volume":"74","author":"M Attanasio","year":"2008","unstructured":"Attanasio M, Lapini I, Evangelisti L, Lucarini L, Giusti B, Porciani M, et al. FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations. Clin Genet. 2008;74:39\u201346.","journal-title":"Clin Genet"},{"key":"899_CR18","first-page":"1017","volume":"20","author":"J Li","year":"2014","unstructured":"Li J, Jia X, Li S, Fang S, Guo X. Mutation survey of candidate genes in 40 Chinese patients with congenital ectopia lentis. Mol Vis. 2014;20:1017\u201324.","journal-title":"Mol Vis"},{"key":"899_CR19","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1172\/JCI117930","volume":"95","author":"DM Milewicz","year":"1995","unstructured":"Milewicz DM, Grossfield J, Cao SN, Kielty C, Covitz W, Jewett T. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Investig. 1995;95:2373\u20138.","journal-title":"J Clin Investig"},{"key":"899_CR20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1242\/jcs.112.7.1093","volume":"112","author":"M Raghunath","year":"1999","unstructured":"Raghunath M, Putnam EA, Ritty T, Hamstra D, Park ES, Tschodrich-Rotter M, et al. Carboxy-terminal conversion of profibrillin to fibrillin at a basic site by PACE\/furin-like activity required for incorporation in the matrix. J Cell Sci. 1999;112:1093\u2013100.","journal-title":"J Cell Sci"},{"key":"899_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ajmg.a.37975","volume":"173","author":"C Dordoni","year":"2017","unstructured":"Dordoni C, Ciaccio C, Santoro G, Venturini M, Cavallari U, Ritelli M, et al. Marfan syndrome: report of a complex phenotype due to a 15q21.1 contiguos gene deletion encompassing FBN1, and literature review. Am J Med Genet Part A. 2017;173:200\u20136.","journal-title":"Am J Med Genet Part A"},{"key":"899_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ejhg.2010.174","volume":"19","author":"Y Hilhorst-Hofstee","year":"2011","unstructured":"Hilhorst-Hofstee Y, Hamel BC, Verheij JB, Rijlaarsdam ME, Mancini GM, Cobben JM, et al. The clinical spectrum of complete FBN1 allele deletions. Eur J Hum Genet. 2011;19:247\u201352.","journal-title":"Eur J Hum Genet"},{"key":"899_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1755-8166-5-5","volume":"5","author":"ME Colovati","year":"2012","unstructured":"Colovati ME, da Silva LR, Takeno SS, et al. Marfan syndrome with a complex chromosomal rearrangement including deletion of the FBN1 gene. Mol Cytogenet. 2012;5:5.","journal-title":"Mol Cytogenet"},{"key":"899_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-12-119","volume":"12","author":"LV Furtado","year":"2011","unstructured":"Furtado LV, Wooderchak-Donahue W, Rope AF, Yetman AT, Lewis T, Plant P, et al. Characterization of large genomic deletions in the FBN1 gene using multiplex ligation-dependent probe amplification. BMC Med Genet. 2011;12:119.","journal-title":"BMC Med Genet"},{"key":"899_CR25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/humu.21525","volume":"32","author":"M Baetens","year":"2011","unstructured":"Baetens M, Van Laer L, De Leeneer K, Hellemans J, De Schrijver J, Van De Voorde H, et al. Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes. Hum Mutat. 2011;32:1053\u201362.","journal-title":"Hum Mutat"},{"key":"899_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1086\/520125","volume":"81","author":"L Faivre","year":"2007","unstructured":"Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet. 2007;81:454\u201366.","journal-title":"Am J Hum Genet"},{"key":"899_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1086\/302582","volume":"65","author":"I Schrijver","year":"1999","unstructured":"Schrijver I, Liu W, Brenn T, Furthmayr H, Francke U. Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. Am J Hum Genet. 1999;65:1007\u201320.","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-021-00899-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-021-00899-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-021-00899-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:09:19Z","timestamp":1684616959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-021-00899-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1038\/s10038-021-00899-w","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was conducted in accordance with the Declaration of Helsinki and was approved by ethics committee of Kanuni Sultan Suleyman Training and Research Hospital (KAEK\/2019.05.134).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}